OBJECTIVE: To examine the differences in the pattern of progression between AD and AD with Lewy bodies (AD+LB). METHODS: The authors examined predictors of functional and cognitive disability, institutionalization, and death, as well as time to the development of psychosis (e.g., delusions, hallucinations), extrapyramidal signs (EPS), diurnal hypersomnia, and depression in 185 patients with definite AD and 60 with autopsy-confirmed AD+LB. In addition, they analyzed a selected group of patients who did not have comorbid systemic or CNS disease that may have affected progression of the disease (AD = 98 versus AD+LB = 44). The mean follow-up was 58.91 +/- 35.2 months. RESULTS: All cases: Patients with AD+LB had faster time to the development of EPS and diurnal hypersomnia, but not to the development of psychosis or depression. The rate of cognitive and functional decline, time to institutionalization, and physical survival was not different between AD+LB and AD. Selected cases: Patients with AD+LB developed earlier EPS and diurnal hypersomnia than AD patients, and there was a trend to develop earlier major depression, but no differences were noted in time to psychosis. Patients with AD+LB had a faster time to institutionalization than those with AD. The rate of cognitive and functional decline and physical survival was not different between AD+LB and AD in these selected cases. CONCLUSION: Patients with AD+LB can develop EPS and diurnal hypersomnia earlier and have faster time to institutionalization than those with AD alone, but cognitive and functional decline and physical survival are similar between these two entities.
OBJECTIVE: To examine the differences in the pattern of progression between AD and AD with Lewy bodies (AD+LB). METHODS: The authors examined predictors of functional and cognitive disability, institutionalization, and death, as well as time to the development of psychosis (e.g., delusions, hallucinations), extrapyramidal signs (EPS), diurnal hypersomnia, and depression in 185 patients with definite AD and 60 with autopsy-confirmed AD+LB. In addition, they analyzed a selected group of patients who did not have comorbid systemic or CNS disease that may have affected progression of the disease (AD = 98 versus AD+LB = 44). The mean follow-up was 58.91 +/- 35.2 months. RESULTS: All cases: Patients with AD+LB had faster time to the development of EPS and diurnal hypersomnia, but not to the development of psychosis or depression. The rate of cognitive and functional decline, time to institutionalization, and physical survival was not different between AD+LB and AD. Selected cases: Patients with AD+LB developed earlier EPS and diurnal hypersomnia than ADpatients, and there was a trend to develop earlier major depression, but no differences were noted in time to psychosis. Patients with AD+LB had a faster time to institutionalization than those with AD. The rate of cognitive and functional decline and physical survival was not different between AD+LB and AD in these selected cases. CONCLUSION:Patients with AD+LB can develop EPS and diurnal hypersomnia earlier and have faster time to institutionalization than those with AD alone, but cognitive and functional decline and physical survival are similar between these two entities.
Authors: Dawn P Gill; Thomas D Koepsell; Rebecca A Hubbard; Walter A Kukull Journal: Alzheimer Dis Assoc Disord Date: 2011 Jan-Mar Impact factor: 2.703
Authors: Eun Joo Chung; Ganesh M Babulal; Sarah E Monsell; Nigel J Cairns; Catherine M Roe; John C Morris Journal: JAMA Neurol Date: 2015-07 Impact factor: 18.302
Authors: Seong Hye Choi; Mikel Olabarrieta; Oscar L Lopez; Victoria Maruca; Steven T Dekosky; Ronald L Hamilton; James T Becker Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: Dawn P Gill; Rebecca A Hubbard; Thomas D Koepsell; Michael J Borrie; Robert J Petrella; David S Knopman; Walter A Kukull Journal: Alzheimers Dement Date: 2013-05-02 Impact factor: 21.566